Hepatitis B virus infection
JL Dienstag - New England Journal of Medicine, 2008 - Mass Medical Soc
JL Dienstag
New England Journal of Medicine, 2008•Mass Medical SocMore effective and less resistance-prone antiviral agents are now available to treat hepatitis
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and
reverse the progression of chronic HBV infection is important, given the evidence linking
high-level HBV replication and the late consequences of chronic HBV infection. This article
reviews strategies for treating HBV infection.
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and
reverse the progression of chronic HBV infection is important, given the evidence linking
high-level HBV replication and the late consequences of chronic HBV infection. This article
reviews strategies for treating HBV infection.
More effective and less resistance-prone antiviral agents are now available to treat hepatitis B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and reverse the progression of chronic HBV infection is important, given the evidence linking high-level HBV replication and the late consequences of chronic HBV infection. This article reviews strategies for treating HBV infection.
The New England Journal Of Medicine